Regarding SFRP5, we reported a higher mRNA relative expression in NAFLD patients than in NL in SAT (Figure 4A) and also in VAT (Figure 4B). The gene discussed is SFRP5; the disease is metabolic dysfunction-associated steatotic liver disease.